HTFL heartflow.com: Multiplikator forward rega marang pendapatan

HeartFlow Inc (HTFL) holds a leading position in AI-driven blood flow analytics, benefiting from high trust among global cardiologists. The company's forward P/S dynamics reflect its real-time market valuation, where 24.50 determines the current status of the parameter. Growth potential is driven by strong data scientists and close partnerships with clinics to implement cloud-based non-invasive diagnostic services.

HTFL (HeartFlow) riwayat Rega forward marang dodolan saka 09.08.2025 nganti 13.11.2026

HeartFlow Medical - rincian analitis lan metrik utama (HTFL)

- rega pasar lan target rega analis:

Bagan rega HeartFlow Inc|HTFL - Rata-rata rega prakiraan

- data kapitalisasi saham perusahaan:

Biji pasar HeartFlow Medical|HTFL - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- rincian valuasi buku bisnis:

Nilai Akuntansi saben Saham HeartFlow|HTFL - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku heartflow.com|HTFL - Gunggung Aset Perusahaan

- data tingkat utang lan likuiditas finansial:

- indikator pendapatan resik lan kelipatan nilai:

HTFL - Bathi sawise pajeg|Bathi sing dikarepake Heartflow Inc|HTFL - Rasio rega marang bathi|Pangali Forward P/E HeartFlow, Inc.|HTFL - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA HeartFlow Medical|HTFL - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) HeartFlow|HTFL - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan heartflow.com|HTFL - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Heartflow Inc

- statistik dodolan lan pendapatan perusahaan:

HTFL - Total dodolan perusahaan|Prakiraan volume dodolan HeartFlow Medical|HTFL - Rasio kapitalisasi pasar marang pendapatan|Multiplikator Forward P/S HeartFlow Medical

Analisis kabeh metrik perusahaan:HeartFlow HTFL

Forward P/S measures the market premium for business scalability potential by relating current market capitalization to projected sales volume. Analyzing the forward P/S of the business allows for the rapid adjustment of the valuation of Heartflow Inc (HTFL) upon the release of quarterly reports, reflecting market confidence in the expansion of cloud-based AI services for ischemia diagnostics and the monetization efficiency of high-tech medical tests.

Pesaing wigati

Rasio rega marang prakiraan pendapatan Regeneron REGN|iRhythm Technologies, Inc. (IRTC) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|LNTH: Multiplikator forward rega marang pendapatan|Mineralys Corp (MLYS) - Multiplikator forward rega marang pendapatan|KMTS (Kestra Medical Technologies) - Multiplikator forward rega marang pendapatan|esperion.com - Rega forward marang dodolan|AMRN (Amarin) - Multiplikator Forward P/S|Anteris Technologies Ltd (AVR) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Tenaya Therapeutics (TNYA)|CVRx Inc - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S MIST (Milestone Pharmaceuticals)|CRDL - Multiplikator forward rega marang pendapatan|HeartBeam - Multiplikator Forward P/S|Rega forward marang dodolan TENX (Tenax Therapeutics Inc.)|ADGM (Adagio Medical Holdings Inc.) - Multiplikator forward rega marang pendapatan|BCDA: Rasio rega marang pendapatan sing dikarepake|VTAK (Catheter Precision) - Multiplikator Forward P/S|ARCA Bio - Rega mangsa ngarep marang pendapatan|Rasio rega marang prakiraan pendapatan Acasti Pharma (ACST)|Rasio rega marang prakiraan pendapatan AVTE (Aerovate Therapeutics Inc.)|Multiplikator Forward P/S VERV (Verve Therapeutics, Inc.)|Rega forward marang dodolan WINT